semaglutide approval Novo Nordisk's weight-loss pill wins FDA FDA Approves Oral Semaglutide as

Certain drugs may enhance the glucose-lowering effects of sulfonylureas by inhibition of their hepatic metabolism (antifungals and monoamine oxidase inhibitors), displacing them from binding to plasma proteins (coumarins, NSAIDs, and sulfonamides), or inhibiting their excretion (probenecid) (22)

Activated protein C therapy slows ALS-like disease in mice by transcriptionally inhibiting SOD1 in motor neurons and microglia cells

a Favor SGLT2 inhibitors or a GLP-1 receptor agonist over placebo

5 Enhances Insulin Sensitivity & Blood Sugar Control Fasting stabilizes blood sugar levels by reducing insulin resistance, a major contributor to diabetes, metabolic syndrome, and weight gain

G.ChakrabartiR.RowlandE